On the other hand, in a study discussing whether SARS-CoV-2 may have an oncogenic potential and its capacity to cause cancer, it was emphasized that it is not yet known whether SARS-CoV-2 works by blocking tumor suppressor molecules such as P53 and stimulating the activation of oncogenes, similar to oncogenic viruses such as HPV, HBV, HBC, HHV4, EBV, HHV8, KSHV, MCPyV and HTLV-1. Here, TP53 is linked to cancer.